Sign in
4

Changes in Ownership

Vivos Therapeutics, Inc. Filed Acc 0001493152-26-040238

Principal Accounting Officer acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Amman Bradford K. Principal Accounting Officer 2026-07-31 Grant or award +250,000 $0.41 $102,500 250,080 D
Derivatives
Amman Bradford K. Principal Accounting Officer 2026-07-31 Grant or award · Stock Option (Right to Buy) +150,000 $0.41 $61,500 326,533 D
Loading xslF345X06/ownership.xml…